Crossmark

Bukiniczia cabulica (Boiss.) Lincz. ameliorate diabetes-induced neuropathy: analgesic, anti-diabetic and anti-neuropathic using enzyme inhibitory, molecular docking and in-vivo studies

Crossref DOI link: https://doi.org/10.1007/s10787-026-02125-5

Published Online: 2026-02-09

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ahmad, Zeeshan

Mir, Mushtaq Ahmad

Shahid, Muhammad

Bashir, Nasreena

Zeb, Alam

Ghufran, Mehreen

Naz, Falak

Ayaz, Muhammad https://orcid.org/0000-0002-4299-2445
License Information

Text and Data Mining valid from 2026-02-09

Version of Record valid from 2026-02-09
More Information

Article History

Received: 29 September 2025

Accepted: 16 January 2026

First Online: 9 February 2026

Declarations

:

: The authors declare no competing interests.

: The animal studies were approved by the Institutional Ethical Committee (reference number: 13/EC-15/Pharm), and the procedures conducted were in accordance with the UK Animals (Scientific Procedures) Act 1986.

: Not Applicable.

Document is current

Any future updates will be listed below